Larissa Heimann

Larissa Heimann

Auto-generated profile, based on publicly available information

Larissa Heimann

Klinik für HNO/Universitätsklinikum des Saarlandes, Homburg/S

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMax Willistein
Max Willistein
DBDominique F. Bechtel
Dominique F. Bechtel
CMChristina S. Müller
Christina S. Müller
UDUlrike Demmer
Ulrike Demmer
LHLarissa Heimann
Larissa Heimann
MBMatthias Boll
Matthias Boll
Hydride transfers play a crucial role in a multitude of biological redox reactions and are mediated by flavin, deazaflavin or nicotinamide adenine dinucleotide cofactors at standard redox potentials ranging from 0 to –340 mV. 2-Naphthoyl-CoA reductase, a key enzyme of oxygen-independent bacterial naphthalene degradation, uses a low-potential one-electron donor for the two-electron dearomatization of its substrate below the redox limit of known biological hydride transfer processes at E°’ = −493 mV. Here we demonstrate by X-ray structural analyses, QM/MM computational studies, and multiple spectroscopy/activity based titrations that highly cooperative electron transfer (n = 3) from a low-potential one-electron (FAD) to a two-electron (FMN) transferring flavin cofactor is the key to overcome the resonance stabilized aromatic system by hydride transfer in a highly hydrophobic pocket. The results evidence how the protein environment inversely functionalizes two flavins to switch from low-potential one-electron to hydride transfer at the thermodynamic limit of flavin redox chemistry.

21 August 2019 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
KSKatharina Sorg
Katharina Sorg
PSPatricia Stahn
Patricia Stahn
LPLukas Pillong
Lukas Pillong
MHMarius P. Hinsberger
Marius P. Hinsberger
LHLarissa Heimann
Larissa Heimann
GWGentiana I. Wenzel
Gentiana I. Wenzel
Hearing impairment is a worldwide problem that affects individuals of all ages. There are 460 million people worldwide with hearing impairment and have problems communicating on a daily basis.1 To compensate for hearing deficit, conventional hearing devices use mechanical energy and, for cases with severe hearing impairment, cochlear implants use electrical energy to stimulate the auditory system. However, for the hard of hearing population who are not yet candidates for cochlear implants and not sufficiently supplied with the currently available auditory prostheses due to multiple reasons, e.g., recurrent outer ear canal inflammations or connectivity issues, further stimulation strategies are needed.2 Light has been considered as an alternative energy form for the activation of the hearing organ, having the advantage to be a noninvasive and precise noncontact activation method.3 – 5 The optical stimulation of the ear has been assessed via three different ways, the infrared neural stimulation (INS),3,6 – 9 the optoacoustic stimulation,10 – 12 as well as optogenetics, the activation of neural structures that are genetically modified to express light-sensitive ion channels.4,13,14 The optoacoustic stimulation is induced by the use of very short laser pulses that are absorbed into the irradiated materials and lead to a short thermal expansion that induces mechanical vibrations. It was first proposed and studied for the optical stimulation of the inner ear using a monochrome laser.15 Recently, we were able to demonstrate that the optoacoustic stimulation has the advantage to induce precise vibrations within all vibrating structures from the ear drum up to the inner ear without the need of direct contact to the vibratory structure.2,16,17 Independent of the final irradiated structure, the biocompatibility of this stimulation method has to be defined and characterized. Up to now, just a few specific biocompatibility studies regarding the laser application at the ear drum are to be found in literature. Foth et al. described the power density limits for the laser-induced thermal effects for laser Doppler vibrometry18 being 7.2  kW/cm2 for the pig TM. Another set of studies described the effects of laser irradiation for the low-level laser therapy (LLLT) of the inner ear19 as well as trans-tympanic photobiomodulation (PBM).20 Both work far below our values using an 830-nm diode laser with power densities of 900  mW/cm2 in the case of LLLT and 909 to 1363  mW/cm2 for PBM. However, due to the fact that they used another wavelength (830 nm) and that the laser parameters were not exactly in the range of our used parameters, these reports could not give us enough safety margins for a clinical application of the optoacoustic stimulation either. In addition, the tympanic membrane (TM) is anatomically very complex. It consists of collagen fibers, embedded in epithelium with mucosa on the middle-ear side and epidermis on the outside21,22 as well as blood vessels. It closes the air-filled tympanic cavity and spans over the bony structure of the malleus. All these together create a very inhomogeneous structure with various absorption characteristics at different locations inducing different laser–tissue interactions. For these reasons, we established a method to assess the biocompatibility margins for light stimulation of the hearing organ and present herein our results regarding the effects of the optoacoustic stimulation with 10-ns 532-nm laser pulses at the TM in a mouse model.

3 September 2021 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
KSKatharina Sorg
Katharina Sorg
LHLarissa Heimann
Larissa Heimann
GLGabriela Moreira Lana
Gabriela Moreira Lana
ALAchim Langenbucher
Achim Langenbucher
BSBernhard Schick
Bernhard Schick
GWGentiana Ioana Wenzel
Gentiana Ioana Wenzel
Optoacoustics is applied in the fields of, e.g., imaging, spectroscopy, and quantification of molecules. The result of the absorption of pulsed light in an absorber medium inducing a thermal expansion and contraction of the substrate and, therefore creating a sound source, represents the optoacoustic effect. This effect can be used to stimulate the hearing organ by inducing vibrations of the irradiated structures. Since optoacoustic stimulation could be applied on every stimulation target in the peripheral hearing system, which could vibrate, e.g., the eardrum or the otic capsule, it offers the potential for use in the development of a new generation of auditory prostheses.

5 March 2021 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
LHLarissa Heimann
Larissa Heimann
CCChristopher Carlein
Christopher Carlein
KSKatharina Sorg
Katharina Sorg
RDRolf Diller
Rolf Diller
ALAchim Langenbucher
Achim Langenbucher
GWGentiana Ioana Wenzel
Gentiana Ioana Wenzel
Significance: Optoacoustic-induced vibrations of the hearing organ can potentially be used for a hearing device. To increase the efficiency of such a hearing device, the conversion of the light energy into vibration energy within each type of irradiated tissue has to be optimized. Aim: To analyze the wavelength-dependency of optoacoustic-induced vibrations within the tympanic membrane (TM), and to define the most efficient and best-suited optical stimulation parameters for a novel auditory prosthesis. Approach: Single nanosecond laser pulses, continuously tunable in a range of visible to near-infrared, were used to excite the guinea pig TM. The induced vibrations of the hearing organ were recorded at the malleus using a laser Doppler vibrometer. Results: Our results indicate a strong wavelength-dependency of the vibration’s amplitude correlating with the superposition of the absorption spectra of the different specific tissue components. Conclusions: We investigated the spectrum of the vibrations of the hearing organ that were induced optoacoustically within a biological membrane embedded in air, in an animal model. First applications for these results can be envisioned for the optical stimulation of the peripheral hearing organ as well as for research purposes.

23 April 2019 in Laryngo-Rhino-Otologie
Verified
Conference Paper
Open access
PDF file
LHL Heimann
L Heimann
NON Oberkircher
N Oberkircher
DHD Hecker
D Hecker
GWG Wenzel
G Wenzel
NGN Graf
N Graf
BSB Schick
B Schick
Das Aminoglykosid (AGL)-Antibiotikum Gentamicin wird bei ausgewählten kinderonkologischen Patienten eingesetzt und kann durch Verlust der äußeren Haarzellen beginnend im Hochtonbereich (> 10 kHz) ototoxische Nebenwirkungen haben. Es besteht daher die Notwendigkeit diese mit einer objektiven, gut reproduzierbaren Methode, zeitnah zu detektieren. Bei 10 onkologischen Kindern und Jugendlichen im Alter von 3 – 17 Jahren wurde vor und nach der Gabe von Gentamicin (tgl. Einmalgabe von 250 mg/m2 KOF; max. 10 mg/kg, max. 400 mg; absolut 4 – 10 mg/kg) ein Hochtonaudiogramm durchgeführt und hochtonausgelöste DPOAEs von 2 kHz bis 16 kHz registriert. Zielgröße war der Signal-Rausch-Abstand (SNR) des Verzerrungsproduktes 2f1-f2. Parallel zum Audiogramm wurden die SNR-Werte jeweils von f2(1)= 2 bis 8 kHz und f2(2)= 10 bis 16 kHz über 20 Ohren in 500 Hz Schritten gemittelt. Die zeitl. Differenz zwischen der AGL-Gabe und der Folgemessung betrug im Median 59 (IQA = 531) Tage. Kinder mit einer Cis- oder Carbonplatin-Therapie wurden von der Studie ausgeschlossen. Vor der AGL-Gabe wurden SNR-Werte von 14,0 dB im unteren (f2(1)) bzw. 7,8 dB im oberen (f2(2)) Frequenzbereich ermittelt. Nach der AGL-Gabe betrug der gemittelte SNR für f2(1)= 15,5 dB und für f2(2)= 9,9 dB. Der t-Test zeigte keine signifikanten Unterschiede. Auch im Tonaudiogramm zeigte sich keine signifikante Verschlechterung der Hörleistung nach Gabe von Gentamicin. Die Registrierung von hochtonausgelösten DPOAEs bis 16 kHz eignet sich hervorragend, um Hörverluste mit einer objektiven, gut reproduzierbaren Methode, zeitnah zu erkennen. Bei den hier untersuchten kinderonkologischen Patienten konnte nach Verabreichung von Gentamicin in der genannten Standarddosis kein ototoxischer Effekt im Hochtonbereich detektiert werden.

9 December 2021
Verified
Conference Paper
Closed access
PDF file
KSKatharina Sorg
Katharina Sorg
LHLarissa Heimann
Larissa Heimann
GLGabriela Moreira Lana
Gabriela Moreira Lana
PSPatricia Stahn
Patricia Stahn
JEJutta Engel
Jutta Engel
GWGentiana Wenzel
Gentiana Wenzel
The optoacoustic stimulation of the peripheral hearing organ activates the central hearing system. For the potential application in hearing aids, we additionally used an absorber on the tympanic membrane that increased the central neuronal activation.